Neferine Attenuates HDM-Induced Allergic Inflammation by Inhibiting the Activation of Dendritic Cell
- PMID: 37702907
- DOI: 10.1007/s10753-023-01891-6
Neferine Attenuates HDM-Induced Allergic Inflammation by Inhibiting the Activation of Dendritic Cell
Abstract
House dust mite (HDM) acts as an environmental antigen that might cause chronic allergic diseases. Neferine (NEF) shows anti-inflammation therapeutic effects. This study is to explore the protection role of NEF against HDM-induced allergic inflammation. HDM-induced allergic asthmatic C57BL/6J mice models were established. Differential histological staining was used to analyze lung tissue pathological scores. Flow cytometry was used to analyze subtypes and biomarker expression of immune cells. RT-PCR and ELISA were used to test cytokines-related gene and/or protein expression levels. Western blot was performed to investigate the signaling pathway that mediates allergic inflammation from mice lung tissue and bone marrow-derived dendritic cells (BMDCs). H&E and PAS staining results indicate NEF significantly attenuated inflammatory index and the percentage of goblet cells in the lung tissue induced by HDM. The HDM-elevated TH2 and TH17 cells were significantly decreased by NEF; inflammatory cytokines Il-4, Il-13 and Il-17 were dramatically downregulated in the NEF plus HDM group compared with HDM alone. CD40+ and CD86+ DCs, eosinophils and mast cells, and ILC2 cells were decreased by NEF which was elevated under HDM stimulation. In vivo and ex vivo investigations indicated NEF can attenuate the activated NF-κB signaling induced by HDM is involved in allergic inflammatory immune response and regulates cytokines-related gene expression. HDM-activated DCs promoted differentiation of TH2 and TH17 cells but were attenuated by NEF. This study suggests NEF interrupts the overexpression of some cytokines released by DCs, TH2, and TH17 cells; NEF attenuates HDM-induced allergic inflammation via inhibiting NF-κB signaling of DCs.
Keywords: HDM; T helper cell; allergic disease; dendritic cell; inflammation; neferine.
© 2023. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
References
-
- Hu, H., et al. 2022. Mitochondrial VDAC1: A potential therapeutic target of inflammation-related diseases and clinical opportunities. Cells 11(19).
-
- Kay, A.B., 2001 Allergy and allergic diseases. First of two parts. The New England Journal of Medicine 344(1): p. 30–7.
MeSH terms
Substances
Grants and funding
- NO. 82100021/National Natural Science Foundation of China
- NO. 81900028/National Natural Science Foundation of China
- NO. 2022YFS0629/Sichuan Science and Technology Program
- NO. 2020LZXNYDJ24/Foundation of Luzhou Science and Technology Program and Southwest Medical University
- NO. 2021LZXNYD-J19/Foundation of Luzhou Science and Technology Program and Southwest Medical University
LinkOut - more resources
Full Text Sources
Medical
Research Materials